A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors
Clinical trial NCT04158583 · TERMINATED
Trial details
- NCT number
- NCT04158583
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-09
- Primary completion
- 2022-07-21
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.